Study Evaluating Telemonitoring and Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAPES Program) Compared to Standard of Care in Patients With Chronic Respiratory Failure Receiving Non-invasive Home Ventilation (e-VENT)

This is an interventional health services research trial for Chronic Respiratory Failure With Hypercapnia focused on measuring Non-invasive ventilation, Telemonitoring, Remote Patient Management, ETAPES, Home healthcare provider, Chronic Care Connect Pneumology Read More

Inclusion Criteria:

• Patient with chronic respiratory failure for whom treatment with home NIV was prescribed at inclusion or two months earlier, and whose service provider is ADEP Assistance, ADAIR Assistance, ARAIR Assistance or VitalAire,

• Patient who meets all eligibility criteria to participate in the ETAPES program, namely:

  • Patient aged 18 and over;
  • Patient receiving NIV as part of an indication recognized by the Société de Pneumologie de Langue Française and the Haute Autorité de Santé;
• Patient never before included in the ETAPES program for the remote medical monitoring of their chronic respiratory failure;
• Patient having agreed to participate in the ETAPES program with the Chronic Care Connect Pneumology solution operated by the service providers ADEP Assistance, ADAIR Assistance, ARAIR Assistance or VitalAire, in the event that they are randomized to the Remote Medical Monitoring group;
• Patient agreeing to the collection of data from their ventilator via remote transmission;
• Patient fitted with a ventilator compatible with the Chronic Care Connect Pneumology solution;
• Patient with health insurance cover;
• Patient who has signed the consent form for the study.

Exclusion Criteria:

• Patient who has any of the non-eligibility criteria for the ETAPES program:

  • Physical or mental inability to use all components of the remote medical monitoring project, as determined by the doctor wishing to include the patient in the remote medical monitoring project;
  • Patient with cancer with a life expectancy of less than 12 months estimated by the pulmonologist;
  • Patient with more than three COPD respiratory decompensations resulting in hospitalization within the previous 12 months;
  • Patient with diagnosed neuromuscular disease;
  • Estimated poor compliance or standard adherence to treatment according to the physician including the patient;
  • Patient's refusal of treatment support;
  • No permanent place of residence;
• Patient participating in another intervention research program.